HCP PLASTENE BULKPACK LIMITED (HPBL.BO)
INR 162.5
(-0.61%)
INR 162.5
(-0.61%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 2.94 Billion | 3.51 Billion | 1.12 Billion | 158.71 Million | 5.96 Million | 1.68 Billion |
| Cost of Revenue | 2.25 Billion | 3.31 Billion | 1.08 Billion | 207.23 Million | 167.47 Million | 2.08 Billion |
| Gross Profit | 694.94 Million | 195.25 Million | 35.15 Million | -48.51 Million | -161.51 Million | -400.75 Million |
| Operating Expenses | 601.26 Million | 89.9 Million | 30.99 Million | 242.44 Million | 10.16 Million | 364.85 Million |
| Selling, General and Administrative Expenses | 601.26 Million | 80.5 Million | 30.43 Million | 199.22 Million | 10.16 Million | 363.53 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -9.4 Million | -567 Thousand | -43.21 Million | - | -1.32 Million |
| Cost and Expenses | 2.85 Billion | 3.4 Billion | 1.11 Billion | 449.67 Million | 177.64 Million | 2.44 Billion |
| Operating Income | 93.68 Million | 105.35 Million | 4.15 Million | -290.95 Million | -171.68 Million | -765.61 Million |
| Interest Expense | 117.3 Million | 93.56 Million | 40.47 Million | 12.75 Million | 39.59 Million | 122.45 Million |
| Income Tax Expense | -1.08 Million | 4.23 Million | -7.09 Million | -200.93 Million | -3.31 Million | -2.66 Million |
| Earnings before Tax | 1.99 Million | 11.84 Million | -31.59 Million | 435.29 Million | -210.35 Million | -892.74 Million |
| Net Income | -11.86 Million | -22.12 Million | -30.47 Million | 636.23 Million | -207.03 Million | -890.08 Million |
| Earnings Per Share Basic | -1.11 | -2.16 | -2.98 | 65.79 | -651.57 | -3002.09 |
| Earnings Per Share Diluted | -1.11 | -2.16 | -2.98 | 65.79 | -651.57 | -3002.09 |
| Weighted Average Shares Outstanding | 10.67 Million | 10.23 Million | 10.23 Million | 9.67 Million | 317.74 Thousand | 296.48 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 10.67 Million | 10.23 Million | 10.23 Million | 9.67 Million | 317.74 Thousand | 296.48 Thousand |
| Gross Margin | 0.24 | 0.06 | 0.03 | -0.31 | -27.10 | -0.24 |
| EBIT Margin | 0.06 | 0.05 | 0.05 | -1.51 | -19.14 | -0.42 |
| Profit Margin | -0.00 | -0.01 | -0.03 | 4.01 | -34.74 | -0.53 |
| EBITDA | 191.16 Million | 179.28 Million | 61.3 Million | -239.73 Million | -114.09 Million | -705.56 Million |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.00 | -1.83 | -28.81 | -0.45 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.04 Billion | 2.94 Billion | 766.34 Million | 796.79 Million | 788.67 Million | 593.74 Million |
| Cost of Revenue | 836.65 Million | 2.25 Billion | 550.33 Million | 605.57 Million | 608.2 Million | 486.48 Million |
| Gross Profit | 210.29 Million | 694.94 Million | 216.01 Million | 191.22 Million | 180.46 Million | 107.25 Million |
| Operating Expenses | 161.24 Million | 601.26 Million | 179.24 Million | 159.53 Million | 150.94 Million | 111.53 Million |
| Selling, General and Administrative Expenses | 161.24 Million | - | 179.24 Million | 159.53 Million | 150.94 Million | 111.53 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 997.9 Million | 2.85 Billion | 729.58 Million | 765.11 Million | 759.14 Million | 598.02 Million |
| Operating Income | 49.05 Million | 93.68 Million | 36.76 Million | 31.68 Million | 29.52 Million | -4.28 Million |
| Interest Expense | 33.3 Million | 117.3 Million | 34.49 Million | 30.67 Million | 27.17 Million | 24.96 Million |
| Income Tax Expense | 7.5 Million | -1.08 Million | 2.41 Million | 201 Thousand | 1.6 Million | -5.3 Million |
| Earnings before Tax | 28.75 Million | 1.99 Million | 14.5 Million | 3.01 Million | 11.2 Million | -26.73 Million |
| Net Income | 14.47 Million | -11.86 Million | 5.57 Million | -4.51 Million | 2.17 Million | -15.09 Million |
| Earnings Per Share Basic | 1.99 | - | 1.28 | -0.42 | 0.20 | -1.41 |
| Earnings Per Share Diluted | 1.97 | - | 1.28 | -0.42 | 0.20 | -1.41 |
| Weighted Average Shares Outstanding | 7.27 Million | 10.67 Million | 10.67 Million | 10.67 Million | 10.67 Million | 10.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 7.34 Million | 10.67 Million | 10.67 Million | 10.67 Million | 10.67 Million | 10.67 Million |
| Gross Margin | 0.20 | 0.24 | 0.28 | 0.24 | 0.23 | 0.18 |
| EBIT Margin | 0.06 | - | 0.07 | 0.06 | 0.06 | 0.02 |
| Profit Margin | 0.01 | -0.00 | 0.01 | -0.01 | 0.00 | -0.03 |
| EBITDA | 66.14 Million | - | 54.71 Million | 49.82 Million | 48.39 Million | 13.72 Million |
| Earnings Before Tax Margin | 0.05 | 0.03 | 0.05 | 0.04 | 0.04 | -0.01 |
PGID
TBN
RECV3
SESPF
SUNPHARMA
CCR